Evidence map›Paper›PMID 40115757›Full record

ArticleWorld journal of experimental medicine2025

Prevalence of

Hoda M Abd El-Ghany, Mona S El Ashry, Mona S Abdellateif, Ahmed Rabea, Nada Sultan, Omnia Y Abd El Dayem

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. [Clinical characteristics of RUNX1-mutated acute myeloid leukemia patients].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hoda M Abd El-GhanyDepartment of Clinical Pathology, Faculty of Medicine, Cairo University, Cairo 11976, Al Qāhirah, Egypt.
Mona S El AshryDepartment of Clinical Pathology, National Cancer Institute, Cairo University, Cairo 11976, Al Qāhirah, Egypt.
Mona S AbdellateifDepartment of Cancer Biology, National Cancer Institute, Cairo University, Cairo 11976, Al Qāhirah, Egypt. mona.sayed@nci.cu.edu.eg.
Ahmed RabeaDepartment of Medical Oncology, National Cancer Institute, Cairo University, Cairo 11976, Al Qāhirah, Egypt.
Nada SultanDepartment of Clinical Pathology, National Cancer Institute, Cairo University, Cairo 11976, Al Qāhirah, Egypt.
Omnia Y Abd El DayemDepartment of Clinical Pathology, Faculty of Medicine, Cairo University, Cairo 11976, Al Qāhirah, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute myeloid leukemia (AML) is a complicated disease with uncontrolled hematopoietic precursor proliferation induced by various genetic alterations. Runt-related transcription factor-1 (

aimTo characterize

methodsFluorescence in situ hybridization was used to test

results

conclusion

Indexed as

Acute myeloid leukemiaDeletionDisease-free survivalFluorescence in-situ hybridizationKaryotypingRUNX1

Identifiers

PMID40115757
PMCPMC11718583

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.